Innovating Works

PREPARE

Financiado
PREcision medicine to Prevent ARrhythmic Events in athletes
Regular physical activity is known to be beneficial for health, can prevent cardiovascular disease and reduce overall mortality. However, high intensity exercise can promote the development of arrhythmias and cause sudden cardiac... Regular physical activity is known to be beneficial for health, can prevent cardiovascular disease and reduce overall mortality. However, high intensity exercise can promote the development of arrhythmias and cause sudden cardiac death. Recently the Prof.Peter Schwartz’s group discovered the phenomenon of exercise-induced Long QT Syndrome (exiLQTS). Affected athletes develop significant QT interval prolongation and repolarization abnormalities on the electrocardiogram during training periods and normalisation occurs during detraining. Clinically, these athletes resemble patients with congenital LQTS, who are known to be severely at risk for life-threatening arrhythmias, but no pathogenic genetic variants in main genes responsible for LQTS were found. Data on how exercise could trigger pathogenic QT prolongation and arrhythmias is limited and thus the possibilities to evaluate potential risks and prevent sudden cardiac death in these young athletes are currently absent. This project will use a precision medicine approach to reveal molecular culprits of exiLQTS by: i) demonstrating that the disease could be recapitulated in vitro using athlete-specific induced pluripotent stem cell-derived cardiomyocytes models; ii) creating a statistical model integrating genetic, electrophysiological, and molecular data; iii) discovering major factors responsible for exiLQTS development and identifying molecular targets for risk stratification and therapy. Results of the study will shed the light on mysterious exercise-related QT prolongation and will contribute to better risk assessment and clinical management of arrhythmias in young athletes. ver más
31/12/2025
AUX
189K€
Perfil tecnológico estimado
Duración del proyecto: 31 meses Fecha Inicio: 2023-05-08
Fecha Fin: 2025-12-31

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-08
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022
Cerrada hace 2 años
Presupuesto El presupuesto total del proyecto asciende a 189K€
Líder del proyecto
ISTITUTO AUXOLOGICO ITALIANO No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5